Abemaciclib 150mg tablets
NHS hospitals in England used £74,861,096 of indicative cost of Abemaciclib 150mg tablets in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is down 4.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Abemaciclib 150mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Abemaciclib 150mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £5,478,150 |
| The Royal Marsden Nhs Foundation Trust | £2,802,237 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,602,638 |
| Nottingham University Hospitals Trust | £2,260,438 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,259,700 |
| Sheffield Teaching Hospitals Nhs Trust | £2,039,188 |
| Derby Teaching Hospitals Nhs Found Trust | £2,009,161 |
| East And North Hertfordshire Nhs Trust | £1,652,000 |
| Royal Surrey County Hosp Nhs Found Trust | £1,564,238 |
| Gloucestershire Hpls Nhs Foundation Trst | £1,510,084 |
The primary-care picture
Abemaciclib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Abemaciclib medicine page.